Table of Contents 1 Market Overview 1.1 Mental Illness Drugs Introduction 1.2 Market Analysis by Type 1.2.1 Antipsychotics 1.2.2 Antidepressants 1.2.3 Antianxiety (anxiolyitcs) 1.2.4 Anti-seizure medications 1.2.5 Stimulants 1.2.6 Cognitive disorders and dementia 1.2.7 Sleep disorder treatments 1.2.8 Substance abuse treatments 1.3 Market Analysis by Applications 1.3.1 Hospital 1.3.2 Clinic 1.3.3 Drugstore 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexico) 1.4.1.1 United States Market States and Outlook (2013-2023) 1.4.1.2 Canada Market States and Outlook (2013-2023) 1.4.1.3 Mexico Market States and Outlook (2013-2023) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2013-2023) 1.4.2.2 France Market States and Outlook (2013-2023) 1.4.2.3 UK Market States and Outlook (2013-2023) 1.4.2.4 Russia Market States and Outlook (2013-2023) 1.4.2.5 Italy Market States and Outlook (2013-2023) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.3.1 China Market States and Outlook (2013-2023) 1.4.3.2 Japan Market States and Outlook (2013-2023) 1.4.3.3 Korea Market States and Outlook (2013-2023) 1.4.3.4 India Market States and Outlook (2013-2023) 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023) 1.4.4 South America, Middle East and Africa 1.4.4.1 Brazil Market States and Outlook (2013-2023) 1.4.4.2 Egypt Market States and Outlook (2013-2023) 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023) 1.4.4.4 South Africa Market States and Outlook (2013-2023) 1.4.4.5 Nigeria Market States and Outlook (2013-2023) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Johnson and Johnson 2.1.1 Business Overview 2.1.2 Mental Illness Drugs Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Johnson and Johnson Mental Illness Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2 Pfizer 2.2.1 Business Overview 2.2.2 Mental Illness Drugs Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Pfizer Mental Illness Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3 Eli Lilly 2.3.1 Business Overview 2.3.2 Mental Illness Drugs Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Eli Lilly Mental Illness Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4 GlaxoSmithKline 2.4.1 Business Overview 2.4.2 Mental Illness Drugs Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 GlaxoSmithKline Mental Illness Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5 AstraZeneca 2.5.1 Business Overview 2.5.2 Mental Illness Drugs Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 AstraZeneca Mental Illness Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6 Bristol-Myers Squibb 2.6.1 Business Overview 2.6.2 Mental Illness Drugs Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Bristol-Myers Squibb Mental Illness Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 3 Global Mental Illness Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017) 3.1 Global Mental Illness Drugs Sales and Market Share by Manufacturer (2016-2017) 3.2 Global Mental Illness Drugs Revenue and Market Share by Manufacturer (2016-2017) 3.3 Market Concentration Rate 3.3.1 Top 3 Mental Illness Drugs Manufacturer Market Share in 2017 3.3.2 Top 6 Mental Illness Drugs Manufacturer Market Share in 2017 3.4 Market Competition Trend 4 Global Mental Illness Drugs Market Analysis by Regions 4.1 Global Mental Illness Drugs Sales, Revenue and Market Share by Regions 4.1.1 Global Mental Illness Drugs Sales and Market Share by Regions (2013-2018) 4.1.2 Global Mental Illness Drugs Revenue and Market Share by Regions (2013-2018) 4.2 North America Mental Illness Drugs Sales and Growth Rate (2013-2018) 4.3 Europe Mental Illness Drugs Sales and Growth Rate (2013-2018) 4.4 Asia-Pacific Mental Illness Drugs Sales and Growth Rate (2013-2018) 4.5 South America Mental Illness Drugs Sales and Growth Rate (2013-2018) 4.6 Middle East and Africa Mental Illness Drugs Sales and Growth Rate (2013-2018) 5 North America Mental Illness Drugs by Countries 5.1 North America Mental Illness Drugs Sales, Revenue and Market Share by Countries 5.1.1 North America Mental Illness Drugs Sales and Market Share by Countries (2013-2018) 5.1.2 North America Mental Illness Drugs Revenue and Market Share by Countries (2013-2018) 5.2 United States Mental Illness Drugs Sales and Growth Rate (2013-2018) 5.3 Canada Mental Illness Drugs Sales and Growth Rate (2013-2018) 5.4 Mexico Mental Illness Drugs Sales and Growth Rate (2013-2018) 6 Europe Mental Illness Drugs by Countries 6.1 Europe Mental Illness Drugs Sales, Revenue and Market Share by Countries 6.1.1 Europe Mental Illness Drugs Sales and Market Share by Countries (2013-2018) 6.1.2 Europe Mental Illness Drugs Revenue and Market Share by Countries (2013-2018) 6.2 Germany Mental Illness Drugs Sales and Growth Rate (2013-2018) 6.3 UK Mental Illness Drugs Sales and Growth Rate (2013-2018) 6.4 France Mental Illness Drugs Sales and Growth Rate (2013-2018) 6.5 Russia Mental Illness Drugs Sales and Growth Rate (2013-2018) 6.6 Italy Mental Illness Drugs Sales and Growth Rate (2013-2018) 7 Asia-Pacific Mental Illness Drugs by Countries 7.1 Asia-Pacific Mental Illness Drugs Sales, Revenue and Market Share by Countries 7.1.1 Asia-Pacific Mental Illness Drugs Sales and Market Share by Countries (2013-2018) 7.1.2 Asia-Pacific Mental Illness Drugs Revenue and Market Share by Countries (2013-2018) 7.2 China Mental Illness Drugs Sales and Growth Rate (2013-2018) 7.3 Japan Mental Illness Drugs Sales and Growth Rate (2013-2018) 7.4 Korea Mental Illness Drugs Sales and Growth Rate (2013-2018) 7.5 India Mental Illness Drugs Sales and Growth Rate (2013-2018) 7.6 Southeast Asia Mental Illness Drugs Sales and Growth Rate (2013-2018) 8 South America Mental Illness Drugs by Countries 8.1 South America Mental Illness Drugs Sales, Revenue and Market Share by Countries 8.1.1 South America Mental Illness Drugs Sales and Market Share by Countries (2013-2018) 8.1.2 South America Mental Illness Drugs Revenue and Market Share by Countries (2013-2018) 8.2 Brazil Mental Illness Drugs Sales and Growth Rate (2013-2018) 8.3 Argentina Mental Illness Drugs Sales and Growth Rate (2013-2018) 8.4 Colombia Mental Illness Drugs Sales and Growth Rate (2013-2018) 9 Middle East and Africa Mental Illness Drugs by Countries 9.1 Middle East and Africa Mental Illness Drugs Sales, Revenue and Market Share by Countries 9.1.1 Middle East and Africa Mental Illness Drugs Sales and Market Share by Countries (2013-2018) 9.1.2 Middle East and Africa Mental Illness Drugs Revenue and Market Share by Countries (2013-2018) 9.2 Saudi Arabia Mental Illness Drugs Sales and Growth Rate (2013-2018) 9.3 UAE Mental Illness Drugs Sales and Growth Rate (2013-2018) 9.4 Egypt Mental Illness Drugs Sales and Growth Rate (2013-2018) 9.5 Nigeria Mental Illness Drugs Sales and Growth Rate (2013-2018) 9.6 South Africa Mental Illness Drugs Sales and Growth Rate (2013-2018) 10 Global Mental Illness Drugs Market Segment by Type 10.1 Global Mental Illness Drugs Sales, Revenue and Market Share by Type (2013-2018) 10.1.1 Global Mental Illness Drugs Sales and Market Share by Type (2013-2018) 10.1.2 Global Mental Illness Drugs Revenue and Market Share by Type (2013-2018) 10.2 Antipsychotics Sales Growth and Price 10.2.1 Global Antipsychotics Sales Growth (2013-2018) 10.2.2 Global Antipsychotics Price (2013-2018) 10.3 Antidepressants Sales Growth and Price 10.3.1 Global Antidepressants Sales Growth (2013-2018) 10.3.2 Global Antidepressants Price (2013-2018) 10.4 Antianxiety (anxiolyitcs) Sales Growth and Price 10.4.1 Global Antianxiety (anxiolyitcs) Sales Growth (2013-2018) 10.4.2 Global Antianxiety (anxiolyitcs) Price (2013-2018) 10.5 Anti-seizure medications Sales Growth and Price 10.5.1 Global Anti-seizure medications Sales Growth (2013-2018) 10.5.2 Global Anti-seizure medications Price (2013-2018) 10.6 Stimulants Sales Growth and Price 10.6.1 Global Stimulants Sales Growth (2013-2018) 10.6.2 Global Stimulants Price (2013-2018) 10.7 Cognitive disorders and dementia Sales Growth and Price 10.7.1 Global Cognitive disorders and dementia Sales Growth (2013-2018) 10.7.2 Global Cognitive disorders and dementia Price (2013-2018) 10.8 Sleep disorder treatments Sales Growth and Price 10.8.1 Global Sleep disorder treatments Sales Growth (2013-2018) 10.8.2 Global Sleep disorder treatments Price (2013-2018) 10.9 Substance abuse treatments Sales Growth and Price 10.9.1 Global Substance abuse treatments Sales Growth (2013-2018) 10.9.2 Global Substance abuse treatments Price (2013-2018) 11 Global Mental Illness Drugs Market Segment by Application 11.1 Global Mental Illness Drugs Sales Market Share by Application (2013-2018) 11.2 Hospital Sales Growth (2013-2018) 11.3 Clinic Sales Growth (2013-2018) 11.4 Drugstore Sales Growth (2013-2018) 12 Mental Illness Drugs Market Forecast (2018-2023) 12.1 Global Mental Illness Drugs Sales, Revenue and Growth Rate (2018-2023) 12.2 Mental Illness Drugs Market Forecast by Regions (2018-2023) 12.2.1 North America Mental Illness Drugs Market Forecast (2018-2023) 12.2.2 Europe Mental Illness Drugs Market Forecast (2018-2023) 12.2.3 Asia-Pacific Mental Illness Drugs Market Forecast (2018-2023) 12.2.4 South America Mental Illness Drugs Market Forecast (2018-2023) 12.2.5 Middle East and Africa Mental Illness Drugs Market Forecast (2018-2023) 12.3 Mental Illness Drugs Market Forecast by Type (2018-2023) 12.3.1 Global Mental Illness Drugs Sales Forecast by Type (2018-2023) 12.3.2 Global Mental Illness Drugs Market Share Forecast by Type (2018-2023) 12.4 Mental Illness Drugs Market Forecast by Application (2018-2023) 12.4.1 Global Mental Illness Drugs Sales Forecast by Application (2018-2023) 12.4.2 Global Mental Illness Drugs Market Share Forecast by Application (2018-2023) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Future Trend 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source

List of Tables and Figures Figure Mental Illness Drugs Picture Table Product Specifications of Mental Illness Drugs Figure Global Sales Market Share of Mental Illness Drugs by Types in 2017 Table Mental Illness Drugs Types for Major Manufacturers Figure Antipsychotics Picture Figure Antidepressants Picture Figure Antianxiety (anxiolyitcs) Picture Figure Anti-seizure medications Picture Figure Stimulants Picture Figure Cognitive disorders and dementia Picture Figure Sleep disorder treatments Picture Figure Substance abuse treatments Picture Figure Mental Illness Drugs Sales Market Share by Applications in 2017 Figure Hospital Picture Figure Clinic Picture Figure Drugstore Picture Figure United States Mental Illness Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Canada Mental Illness Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Mexico Mental Illness Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Germany Mental Illness Drugs Revenue (Value) and Growth Rate (2013-2023) Figure France Mental Illness Drugs Revenue (Value) and Growth Rate (2013-2023) Figure UK Mental Illness Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Russia Mental Illness Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Italy Mental Illness Drugs Revenue (Value) and Growth Rate (2013-2023) Figure China Mental Illness Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Japan Mental Illness Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Korea Mental Illness Drugs Revenue (Value) and Growth Rate (2013-2023) Figure India Mental Illness Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Southeast Asia Mental Illness Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Brazil Mental Illness Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Egypt Mental Illness Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Saudi Arabia Mental Illness Drugs Revenue (Value) and Growth Rate (2013-2023) Figure South Africa Mental Illness Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Nigeria Mental Illness Drugs Revenue (Value) and Growth Rate (2013-2023) Table Johnson and Johnson Basic Information, Manufacturing Base and Competitors Table Johnson and Johnson Mental Illness Drugs Type and Applications Table Johnson and Johnson Mental Illness Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Pfizer Basic Information, Manufacturing Base and Competitors Table Pfizer Mental Illness Drugs Type and Applications Table Pfizer Mental Illness Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Eli Lilly Basic Information, Manufacturing Base and Competitors Table Eli Lilly Mental Illness Drugs Type and Applications Table Eli Lilly Mental Illness Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors Table GlaxoSmithKline Mental Illness Drugs Type and Applications Table GlaxoSmithKline Mental Illness Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table AstraZeneca Basic Information, Manufacturing Base and Competitors Table AstraZeneca Mental Illness Drugs Type and Applications Table AstraZeneca Mental Illness Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors Table Bristol-Myers Squibb Mental Illness Drugs Type and Applications Table Bristol-Myers Squibb Mental Illness Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Global Mental Illness Drugs Sales by Manufacturer (2016-2017) Figure Global Mental Illness Drugs Sales Market Share by Manufacturer in 2016 Figure Global Mental Illness Drugs Sales Market Share by Manufacturer in 2017 Table Global Mental Illness Drugs Revenue by Manufacturer (2016-2017) Figure Global Mental Illness Drugs Revenue Market Share by Manufacturer in 2016 Figure Global Mental Illness Drugs Revenue Market Share by Manufacturer in 2017 Figure Top 3 Mental Illness Drugs Manufacturer (Revenue) Market Share in 2017 Figure Top 6 Mental Illness Drugs Manufacturer (Revenue) Market Share in 2017 Figure Global Mental Illness Drugs Sales and Growth Rate (2013-2018) Figure Global Mental Illness Drugs Revenue and Growth Rate (2013-2018) Table Global Mental Illness Drugs Sales by Regions (2013-2018) Table Global Mental Illness Drugs Sales Market Share by Regions (2013-2018) Table Global Mental Illness Drugs Revenue by Regions (2013-2018) Figure Global Mental Illness Drugs Revenue Market Share by Regions in 2013 Figure Global Mental Illness Drugs Revenue Market Share by Regions in 2017 Figure North America Mental Illness Drugs Sales and Growth Rate (2013-2018) Figure Europe Mental Illness Drugs Sales and Growth Rate (2013-2018) Figure Asia-Pacific Mental Illness Drugs Sales and Growth Rate (2013-2018) Figure South America Mental Illness Drugs Sales and Growth Rate (2013-2018) Figure Middle East and Africa Mental Illness Drugs Sales and Growth Rate (2013-2018) Figure North America Mental Illness Drugs Revenue and Growth Rate (2013-2018) Table North America Mental Illness Drugs Sales by Countries (2013-2018) Table North America Mental Illness Drugs Sales Market Share by Countries (2013-2018) Figure North America Mental Illness Drugs Sales Market Share by Countries in 2013 Figure North America Mental Illness Drugs Sales Market Share by Countries in 2017 Table North America Mental Illness Drugs Revenue by Countries (2013-2018) Table North America Mental Illness Drugs Revenue Market Share by Countries (2013-2018) Figure North America Mental Illness Drugs Revenue Market Share by Countries in 2013 Figure North America Mental Illness Drugs Revenue Market Share by Countries in 2017 Figure United States Mental Illness Drugs Sales and Growth Rate (2013-2018) Figure Canada Mental Illness Drugs Sales and Growth Rate (2013-2018) Figure Mexico Mental Illness Drugs Sales and Growth Rate (2013-2018) Figure Europe Mental Illness Drugs Revenue and Growth Rate (2013-2018) Table Europe Mental Illness Drugs Sales by Countries (2013-2018) Table Europe Mental Illness Drugs Sales Market Share by Countries (2013-2018) Table Europe Mental Illness Drugs Revenue by Countries (2013-2018) Figure Europe Mental Illness Drugs Revenue Market Share by Countries in 2016 Figure Europe Mental Illness Drugs Revenue Market Share by Countries in 2017 Figure Germany Mental Illness Drugs Sales and Growth Rate (2013-2018) Figure UK Mental Illness Drugs Sales and Growth Rate (2013-2018) Figure France Mental Illness Drugs Sales and Growth Rate (2013-2018) Figure Russia Mental Illness Drugs Sales and Growth Rate (2013-2018) Figure Italy Mental Illness Drugs Sales and Growth Rate (2013-2018) Figure Asia-Pacific Mental Illness Drugs Revenue and Growth Rate (2013-2018) Table Asia-Pacific Mental Illness Drugs Sales by Countries (2013-2018) Table Asia-Pacific Mental Illness Drugs Sales Market Share by Countries (2013-2018) Figure Asia-Pacific Mental Illness Drugs Sales Market Share by Countries 2017 Table Asia-Pacific Mental Illness Drugs Revenue by Countries (2013-2018) Figure Asia-Pacific Mental Illness Drugs Revenue Market Share by Countries 2017 Figure China Mental Illness Drugs Sales and Growth Rate (2013-2018) Figure Japan Mental Illness Drugs Sales and Growth Rate (2013-2018) Figure Korea Mental Illness Drugs Sales and Growth Rate (2013-2018) Figure India Mental Illness Drugs Sales and Growth Rate (2013-2018) Figure Southeast Asia Mental Illness Drugs Sales and Growth Rate (2013-2018) Figure South America Mental Illness Drugs Revenue and Growth Rate (2013-2018) Table South America Mental Illness Drugs Sales by Countries (2013-2018) Table South America Mental Illness Drugs Sales Market Share by Countries (2013-2018) Figure South America Mental Illness Drugs Sales Market Share by Countries in 2017 Table South America Mental Illness Drugs Revenue by Countries (2013-2018) Table South America Mental Illness Drugs Revenue Market Share by Countries (2013-2018) Figure South America Mental Illness Drugs Revenue Market Share by Countries in 2017 Figure Brazil Mental Illness Drugs Sales and Growth Rate (2013-2018) Figure Argentina Mental Illness Drugs Sales and Growth Rate (2013-2018) Figure Colombia Mental Illness Drugs Sales and Growth Rate (2013-2018) Figure Middle East and Africa Mental Illness Drugs Revenue and Growth Rate (2013-2018) Table Middle East and Africa Mental Illness Drugs Sales by Countries (2013-2018) Table Middle East and Africa Mental Illness Drugs Sales Market Share by Countries (2013-2018) Figure Middle East and Africa Mental Illness Drugs Sales Market Share by Countries in 2017 Table Middle East and Africa Mental Illness Drugs Revenue by Countries (2013-2018) Table Middle East and Africa Mental Illness Drugs Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa Mental Illness Drugs Revenue Market Share by Countries in 2013 Figure Middle East and Africa Mental Illness Drugs Revenue Market Share by Countries in 2017 Figure Saudi Arabia Mental Illness Drugs Sales and Growth Rate (2013-2018) Figure UAE Mental Illness Drugs Sales and Growth Rate (2013-2018) Figure Egypt Mental Illness Drugs Sales and Growth Rate (2013-2018) Figure Nigeria Mental Illness Drugs Sales and Growth Rate (2013-2018) Figure South Africa Mental Illness Drugs Sales and Growth Rate (2013-2018) Table Global Mental Illness Drugs Sales by Type (2013-2018) Table Global Mental Illness Drugs Sales Share by Type (2013-2018) Table Global Mental Illness Drugs Revenue by Type (2013-2018) Table Global Mental Illness Drugs Revenue Share by Type (2013-2018) Figure Global Antipsychotics Sales Growth (2013-2018) Figure Global Antipsychotics Price (2013-2018) Figure Global Antidepressants Sales Growth (2013-2018) Figure Global Antidepressants Price (2013-2018) Figure Global Antianxiety (anxiolyitcs) Sales Growth (2013-2018) Figure Global Antianxiety (anxiolyitcs) Price (2013-2018) Figure Global Anti-seizure medications Sales Growth (2013-2018) Figure Global Anti-seizure medications Price (2013-2018) Figure Global Stimulants Sales Growth (2013-2018) Figure Global Stimulants Price (2013-2018) Figure Global Cognitive disorders and dementia Sales Growth (2013-2018) Figure Global Cognitive disorders and dementia Price (2013-2018) Figure Global Sleep disorder treatments Sales Growth (2013-2018) Figure Global Sleep disorder treatments Price (2013-2018) Figure Global Substance abuse treatments Sales Growth (2013-2018) Figure Global Substance abuse treatments Price (2013-2018) Table Global Mental Illness Drugs Sales by Application (2013-2018) Table Global Mental Illness Drugs Sales Share by Application (2013-2018) Figure Global Clinic Sales Growth (2013-2018) Figure Global Drugstore Sales Growth (2013-2018) Figure Global Mental Illness Drugs Sales, Revenue and Growth Rate (2018-2023) Table Global Mental Illness Drugs Sales Forecast by Regions (2018-2023) Table Global Mental Illness Drugs Market Share Forecast by Regions (2018-2023) Figure North America Sales Mental Illness Drugs Market Forecast (2018-2023) Figure Europe Sales Mental Illness Drugs Market Forecast (2018-2023) Figure Asia-Pacific Sales Mental Illness Drugs Market Forecast (2018-2023) Figure South America Sales Mental Illness Drugs Market Forecast (2018-2023) Figure Middle East and Africa Sales Mental Illness Drugs Market Forecast (2018-2023) Table Global Mental Illness Drugs Sales Forecast by Type (2018-2023) Table Global Mental Illness Drugs Market Share Forecast by Type (2018-2023) Table Global Mental Illness Drugs Sales Forecast by Application (2018-2023) Table Global Mental Illness Drugs Market Share Forecast by Application (2018-2023) Table Distributors/Traders/ Dealers List

Johnson and Johnson Pfizer Eli Lilly GlaxoSmithKline AstraZeneca Bristol-Myers Squibb